Literature DB >> 33675647

Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel.

Gregory Buchek1,2, Katrin Mende1,3,4, Kalyani Telu3,4, Susan Kaiser1,3,4, Jamie Fraser3,4, Indrani Mitra3,4, Jason Stam5, Tahaniyat Lalani3,4, David Tribble3, Heather C Yun1,2.   

Abstract

BACKGROUND: International travel is a risk factor for incident colonization with extended spectrum beta-lactamase (ESBL)-producing organisms. These and other multidrug-resistant (MDR) bacteria are major pathogens in combat casualties. We evaluated risk factors for colonization with MDR bacteria in US military personnel travelling internationally for official duty.
METHODS: TravMil is a prospective observational study enrolling subjects presenting to military travel clinics. We analysed surveys, antimicrobial use data, and pre- and post-travel perirectal swabs in military travellers to regions outside the continental USA, Canada, Western or Northern Europe, or New Zealand, presenting to one clinic from 12/2015 to 12/2017. Recovered Gram-negative isolates underwent identification and susceptibility testing (BD Phoenix). Characteristics of trip and traveller were analysed to determine risk factors for MDR organism colonization.
RESULTS: 110 trips were planned by 99 travellers (74% male, median age 38 years [IQR 31, 47.25]); 72 trips with returned pre- and post-travel swabs were completed by 64 travellers. Median duration was 21 days (IQR 12.75, 79.5). 17% travelled to Mexico/Caribbean/Central America, 15% to Asia, 57% to Africa and 10% to South America; 56% stayed in hotels and 50% in dormitories/barracks. Travellers used doxycycline (15%) for malaria prophylaxis, 11% took an antibiotic for travellers' diarrhoea (TD) treatment (fluoroquinolone 7%, azithromycin 4%). Incident MDR organism colonization occurred in 8 travellers (incidence density 3.5/1000 travel days; cumulative incidence 11% of trips [95% CI: 4-19%]), all ESBL-producing Escherichia coli. A higher incidence of ESBL-producing E. coli acquisition was associated with travel to Asia (36% vs 7%, P = 0.02) but not with travel to other regions, TD or use of antimicrobials. No relationship was seen between fluoroquinolone or doxycycline exposure and resistance to those antimicrobials.
CONCLUSIONS: Incident colonization with MDR organisms occurs at a lower rate in this military population compared with civilian travellers, with no identified modifiable risk factors, with highest incidence of ESBL acquisition observed after South Asia travel. © International Society of Travel Medicine 2021. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Antimicrobials; CTX-M; Colonization; ESBL-producing Enterobacteriaceae; Eschericia coli; Perirectal swab; Whole genome sequencing

Mesh:

Substances:

Year:  2021        PMID: 33675647      PMCID: PMC8045176          DOI: 10.1093/jtm/taab028

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  25 in total

1.  Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors:  Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Bacteriology of war wounds at the time of injury.

Authors:  Clinton K Murray; Stuart A Roop; Duane R Hospenthal; David P Dooley; Kimberly Wenner; John Hammock; Neil Taufen; Emmett Gourdine
Journal:  Mil Med       Date:  2006-09       Impact factor: 1.437

Review 3.  Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene-based approaches.

Authors:  A C Schürch; S Arredondo-Alonso; R J L Willems; R V Goering
Journal:  Clin Microbiol Infect       Date:  2018-01-05       Impact factor: 8.067

4.  Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Authors:  Thomas Tängdén; Otto Cars; Asa Melhus; Elisabeth Löwdin
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

5.  Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers.

Authors:  K Kennedy; P Collignon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-12       Impact factor: 3.267

6.  Multidrug-resistant gram-negative bacilli colonization risk factors among trauma patients.

Authors:  Laura J Gilbert; Ping Li; Clinton K Murray; Heather C Yun; Deepak Aggarwal; Amy C Weintrob; David R Tribble
Journal:  Diagn Microbiol Infect Dis       Date:  2015-12-23       Impact factor: 2.803

Review 7.  Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study.

Authors:  David R Tribble; Nicholas G Conger; Susan Fraser; Todd D Gleeson; Ken Wilkins; Tanya Antonille; Amy Weintrob; Anuradha Ganesan; Lakisha J Gaskins; Ping Li; Greg Grandits; Michael L Landrum; Duane R Hospenthal; Eugene V Millar; Lorne H Blackbourne; James R Dunne; David Craft; Katrin Mende; Glenn W Wortmann; Rachel Herlihy; Jay McDonald; Clinton K Murray
Journal:  J Trauma       Date:  2011-07

8.  Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq.

Authors:  Duane R Hospenthal; Helen K Crouch; Judith F English; Fluryanne Leach; Jane Pool; Nicholas G Conger; Timothy J Whitman; Glenn W Wortmann; Janelle L Robertson; Clinton K Murray
Journal:  J Trauma       Date:  2011-07

9.  Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City.

Authors:  Scott A Weisenberg; Jose R Mediavilla; Liang Chen; Elizabeth L Alexander; Kyu Y Rhee; Barry N Kreiswirth; Stephen G Jenkins
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

10.  Antimicrobial resistance acquisition after international travel in U.S. travelers.

Authors:  Dana M Blyth; Katrin Mende; Ashley M Maranich; Miriam L Beckius; Kristie A Harnisch; Crystal A Rosemann; Wendy C Zera; Clinton K Murray; Kevin S Akers
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-03-14
View more
  1 in total

Review 1.  Antimicrobial-resistant bacteria in international travelers.

Authors:  Sushmita Sridhar; Sarah E Turbett; Jason B Harris; Regina C LaRocque
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.915

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.